CNR1 and Parkinson disease: Huntington’s disease: While PD is characterized by an augmented endocannabinoid tone, a significant reduction in CB1R expression, and also in endocannabinoid levels, has been reported in pre-clinical and clinical studies in HD [379,380,381,382,383,384].